Journals / Şişli Etfal Hastanesi Tıp Bülteni / 2020 / Cilt: 54 - Sayı: 1

The Effects of Laparoscopic Sleeve Gastrectomy on Glucose Metabolism in Patients with a Body Mass Index below 35 kg/m²

Pages
36–40
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was a significant decrease in body mass index compared to the preoperative period.Conclusion: Laparoscopic sleeve gastrectomy is an effective surgery on glucose metabolism in patients with a body mass indexof 30-35kg/m2.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The prevalence of obesity and its associated comorbidities are increasing all over the world.
📊
Key Findings & Data:Laparoscopic sleevegastrectomy has become the most common bariatric surgery in the world today, especially in the treatment of Type 2 diabetesmellitus, which is one of the effective surgical methods.
💡
Conclusion & Impact:There was a significant decrease in body mass index compared to the preoperative period.Conclusion: Laparoscopic sleeve gastrectomy is an effective surgery on glucose metabolism in patients with a body mass indexof 30-35kg/m2.
🔬Design:Modeling & Simulation
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Özet

Objectives: The prevalence of obesity and its associated comorbidities are increasing all over the world. Laparoscopic sleevegastrectomy has become the most common bariatric surgery in the world today, especially in the treatment of Type 2 diabetesmellitus, which is one of the effective surgical methods. The present study aims to investigate the effects on glucose metabolismin patients following laparoscopic sleeve gastrectomy.Methods: In this study, the files of 174 patients who had laparoscopic sleeve gastrectomy with a body mass index between 30-35kg/m2 between March 2013 and September 2019 were analyzed retrospectively. Patients were evaluated by a multidisciplinaryteam in the preoperative period. Patients who met the criteria for laparoscopic sleeve gastrectomy were operated accordingto American Metabolic and Bariatric Surgeons criteria. Demographic data, body mass index, insulin, glycosylated hemoglobin(HbA1c), glucose, homeostasis model insulin resistance (HOMA-IR) values were recorded. The patients were followed up with visitsto the outpatient clinic scheduled for 1-3-6 and 12 months postoperatively.Results: The mean age of the 174 patients who underwent laparoscopic sleeve gastrectomy was 39.57±9.40, and the mean bodymass index was 32.70±2.65. 149 patients (85.6%) were female. The mean hospital stay was 3.1±0.7 days. When glucose, HbA1c,HOMAR-IR and insulin values of the patients were examined, it was observed that the decrease was statistically significant at 12months follow-up. There was a significant decrease in body mass index compared to the preoperative period.Conclusion: Laparoscopic sleeve gastrectomy is an effective surgery on glucose metabolism in patients with a body mass indexof 30-35kg/m2.

🔖

Cite This Article

BATMAN, B., ALTUN, H. (2020). The Effects of Laparoscopic Sleeve Gastrectomy on Glucose Metabolism in Patients with a Body Mass Index below 35 kg/m². Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 54 - Sayı: 1, 36–40. https://ajindex.com/articles/363658

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Diabetes Mellitus – epidemiology
  2. Diabetes Mellitus – prevention and control
  3. Diabetes, Gestational
  4. Chronic Disease
  5. Public Health. I. World Health Organization; NLM classification: WK 810
  6. American Diabetes Association
  7. Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care 2018;41:S65–72
  8. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009;122:248– 56.e5
  9. Haruta H, Kasama K, Ohta M, Sasaki A, Yamamoto H, Miyazaki Y, et al. Long-Term Outcomes of Bariatric and Metabolic Surgery in Japan: Results of a Multi-Institutional Survey. Obes Surg 2017r;27:754–62
  10. Dicker D, Yahalom R, Comaneshter DS, Vinker S. Long-Term Outcomes of Three Types of Bariatric Surgery on Obesity and Type 2 Diabetes Control and Remission. Obes Surg 2016;26:1814–20
  11. Ribaric G, Buchwald JN, McGlennon TW. Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: a systematic review and meta-analysis. Obes Surg 2014;24:437–55
  12. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, et al; STAMPEDE Investigators. Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes. N Engl J Med 2017;376:641–51
  13. Melissas J, Stavroulakis K, Tzikoulis V, Peristeri A, Papadakis JA, Pazouki A, et al. Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass. Data from IFSO-European Chapter Center of Excellence Program. Obes Surg 2017;27:847–55
  14. Langer FB, Reza Hoda MA, Bohdjalian A, Felberbauer FX, Zacherl J, Wenzl E, et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg 2005;15:1024–9
  15. Peterli R, Wölnerhanssen B, Peters T, Devaux N, Kern B, ChristoffelCourtin C, et al. Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann Surg 2009;250:234–41
  16. Mechanick JI, Youdim A, Jones DB, Garvey WT, Hurley DL, McMahon MM, et al; American Association of Clinical Endocrinologists; Obesity Society; American Society for Metabolic & Bariatric Surgery. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesi